StreetInsider.com News Articles

Hub Group, Inc. Securities Fraud Class Action Result of Erroneous Financial Statements and Approximately 31% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Fri, 17 Jul 2026 16:20:00 -0400

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 17, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 28, 2026 to file lead plaintiff applications in a securities class action lawsuit against Hub Group, Inc. ("Hub" or the "Company") (NASDAQ: HUBG), if they purchased or otherwise acquired the Company's securities between April 28, 2023, and May 11, 2026, inclusive (the "Class Period"). This action is pending in the United States District Court for

Hub Group, Inc. Securities Fraud Class Action Result of Erroneous Financial Statements and Approximately 31% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Fri, 17 Jul 2026 16:20:00 -0400

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law O

Tue, 14 Jul 2026 10:26:11 -0400

PHILADELPHIA, July 14, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law O

Tue, 14 Jul 2026 10:26:11 -0400

PHILADELPHIA, July 14, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law O

Tue, 14 Jul 2026 10:26:11 -0400

PHILADELPHIA, July 14, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law O

Tue, 14 Jul 2026 10:26:11 -0400

PHILADELPHIA, July 14, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law O

Tue, 14 Jul 2026 10:26:11 -0400

PHILADELPHIA, July 14, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law O

Tue, 14 Jul 2026 10:26:11 -0400

PHILADELPHIA, July 14, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law O

Tue, 14 Jul 2026 10:26:11 -0400

PHILADELPHIA, July 14, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law O

Tue, 14 Jul 2026 10:26:11 -0400

PHILADELPHIA, July 14, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law O

Tue, 14 Jul 2026 10:26:11 -0400

PHILADELPHIA, July 14, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law O

Tue, 14 Jul 2026 10:26:11 -0400

PHILADELPHIA, July 14, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law O

Tue, 14 Jul 2026 10:26:11 -0400

PHILADELPHIA, July 14, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law O

Tue, 14 Jul 2026 10:26:11 -0400

PHILADELPHIA, July 14, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law O

Tue, 14 Jul 2026 10:26:11 -0400

PHILADELPHIA, July 14, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law O

Tue, 14 Jul 2026 10:26:11 -0400

PHILADELPHIA, July 14, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law O

Tue, 14 Jul 2026 10:26:11 -0400

PHILADELPHIA, July 14, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law O

Tue, 14 Jul 2026 10:26:11 -0400

PHILADELPHIA, July 14, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law O

Tue, 14 Jul 2026 10:26:11 -0400

PHILADELPHIA, July 14, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law O

Tue, 14 Jul 2026 10:26:11 -0400

PHILADELPHIA, July 14, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law O

Tue, 14 Jul 2026 10:26:11 -0400

PHILADELPHIA, July 14, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law O

Tue, 14 Jul 2026 10:26:11 -0400

PHILADELPHIA, July 14, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law O

Tue, 14 Jul 2026 10:26:11 -0400

PHILADELPHIA, July 14, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law O

Tue, 14 Jul 2026 10:26:11 -0400

PHILADELPHIA, July 14, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law O

Tue, 14 Jul 2026 10:26:11 -0400

PHILADELPHIA, July 14, 2026 (GLOBE NEWSWIRE) --

ADMA BIOLOGICS, INC. (NASDAQ: ADMA):

Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary duties to the company and its shareholders.

What Is This Investigation About? Grabar Law Office is investigating allegations that ADMA's officers and directors failed to implement and maintain adequate internal controls and oversight mechanisms concerning the Company's revenue recognition practices, related-party transactions, and public disclosures.

If you purchased ADMA Biologics, Inc. (NASDAQ: ADMA) shares prior to August 9,